Chiesi Farmaceutici to acquire biopharma company Amryt Pharma for $1.5bn
Chiesi Farmaceutici, an Italian biopharmaceuticals and healthcare group, has agreed to acquire Amryt Pharma, a commercial-stage biopharmaceutical company, in an all-cash transaction valued at around $1.48 billion. The transaction value constitutes an upfront payment of around $1.25 billion and an additional $225 million of potential consideration payable if certain milestones related to Amryt Pharma’s Filsuvez […]